Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
Clin Exp Rheumatol
; 40(7): 1258-1266, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-34251312
Full text:
1
Database:
MEDLINE
Main subject:
Rheumatic Diseases
/
COVID-19
/
COVID-19 Drug Treatment
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Clin Exp Rheumatol
Year:
2022
Type:
Article
Affiliation country:
Brazil